Effects of Lutein in Retinitis Pigmentosa
Completed · Phase 1/Phase 2
Conditions studied: Retinitis Pigmentosa
In brief
Phase I/II double-masked, randomized, placebo-controlled, cross-over trial to determine effects of lutein on vision in retinitis pigmentosa, including safety and effective dosage assessment
Key facts
- Study ID
- NCT00029289
- Run by
- National Center for Complementary and Integrative Health (NCCIH)
- Starts
- 2001-04-01
- Expected to finish
- 2002-10-01
- Last updated by the study team
- 2006-08-18
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Johns Hopkins Wilmer Eye Institute, Lions Vision Center — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.